sodium c12-13 pareth-5 carboxylate hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard statements were found for this ingredient; no peer‑reviewed evidence of reproductive toxicity or endocrine activity was identified in regulatory summaries (PubChem/ECHA/CosIng). As an anionic ethoxylated fatty alcohol carboxylate surfactant, systemic absorption from typical topical cosmetic use is low but measurable, so exposure is assigned as low (e=1). Sources: ECHA registration/CosIng/PubChem; absence of ECHA Annex VI harmonised classification and no CIR/SCCS repro findings.
Related ingredients
Frequently asked questions
- sodium c12-13 pareth-5 carboxylate hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard statements were found for this ingredient; no peer‑reviewed evidence of reproductive toxicity or endocrine activity was identified in regulatory summaries (PubChem/ECHA/CosIng). As an anionic ethoxylated fatty alcohol carboxylate surfactant, systemic absorption from typical topical cosmetic use is low but measurable, so exposure is assigned as low (e=1). Sources: ECHA registration/CosIng/PubChem; absence of ECHA Annex VI harmonised classification and no CIR/SCCS repro findings.
- sodium c12-13 pareth-5 carboxylate emzirirken güvenli mi?
- Same rationale as pregnancy: no evidence of reproductive or lactation-specific toxicity in regulatory databases or safety assessments. Dermal use leads to low but measurable systemic exposure in adults, so breastfeeding exposure is scored low (e=1).
- sodium c12-13 pareth-5 carboxylate bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental toxicity evidence was found. Because infant skin has higher permeability, exposure score is increased by +1 relative to adult (adult e=1 → infant e=2). No data indicating direct dermal developmental hazard in 0–3 yr olds were identified in CIR/SCCS/ECHA summaries.
- VeriMom sodium c12-13 pareth-5 carboxylate nasıl puanlıyor?
- VeriMom sodium c12-13 pareth-5 carboxylate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte sodium c12-13 pareth-5 carboxylate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.